Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

Showcasing the local bounty Montana has to offer has become a driving force for Chef Brandon Dearden at his two Hamilton restaurants, Ember and Grano. While Ember showcases Montana beef coupled ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

But, increased costs became a drag on net income in 2023 as firms invested in technology and infrastructure. Further ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...